• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Well Health Nabs $45M to Expand Intelligent Communications Hub

Share:

December 1, 2020

Highlights on this story:
  • WELL Health raises $45M in Series C funding to transform patient communication for healthcare providers, payers, and ACOs.
  • WELL Health enables conversations between patients and healthcare organizations through secure, multilingual messaging in the patient’s preferred communications channel: texting, email, telephone, and live chat.

Well Health Inc., a Santa Barbara, CA-based provider of patient communications, today announced a $45 million Series C funding round led by Lead Edge Capital, bringing total funds raised to $75 million since its founding in 2015. Additional participants include Martin Ventures, the healthcare-focused venture capital firm founded by executive, investor, and entrepreneur, Charlie Martin, and existing investors Jackson Square Ventures, Health Velocity Capital, Summation Health Ventures, Structure Capital and Freestyle Capital. This is the first investment publicly announced by WELL Health and follows more than 100 percent cumulative annual growth every year since its founding.

Improving Patient Conversations for A Better Healthcare Experience

Healthcare providers, payers and ACOs are under tremendous pressure to innovate their patient-engagement methods. Founded in 2015, WELL Health’s intelligent communications hub is the only two-way digital health solution engaging patients throughout their entire care experience from patient acquisition to service delivery and ultimately at their homes. WELL Health enables conversations between patients and healthcare organizations through secure, multilingual messaging in the patient’s preferred communications channel: texting, email, telephone, and live chat. By unifying and automating patient interactions across an organization, WELL Health’s technology enables greater efficiency, improved patient experience, better coordination among provider staff, and stronger patient loyalty.

Dana Gelb Safran, Sc.D. Joins WELL Health

WELL Health also announced that industry veteran Dana Gelb Safran, Sc.D. has joined as Senior Vice President, Value Based Care and Population Health. In her new role as SVP, Value Based Care and Population Health, Dr. Safran will expand WELL’s uses to improve healthcare quality, outcomes and affordability through partnerships with payers and Accountable Care Organization (ACO) providers.

This Series C news follows a recently announced collaboration between WELL and Cerner Corporation, an electronic health records (EHR) leader, making WELL Health the patient-communication solution for Cerner’s customers. With solutions for health systems, provider practices, home health organizations, federally qualified health centers (FQHCs) and other provider organizations, WELL Health’s intelligent communications hub integrates with all major EHRs and patient payment platforms safely and securely.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“WELL delivers what patients expect today – the ability to engage with their healthcare provider as easily as they’d text a friend,” said Guillaume de Zwirek, CEO and founder, Well Health Inc. “Although the pandemic fueled the adoption of digital health by many healthcare providers, patients today expect real-time, personalized communication, an expectation that will never fade. This year alone, WELL technology will enable 200k+ healthcare providers to send more than 1 billion messages with 30+ million patients.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Verily, Sosei Heptares Collaborate to Generate Novel Drug Candidates Against GPCR Targets for Immune-Mediated DiseasesVerily, Sosei Heptares Collaborate to Generate Novel Drug Candidates Against GPCR Targets for Immune-Mediated Diseases
  • AI drug development partnership between GlaxoSmithKline, Exscientia yields first drug candidateAI drug development partnership between GlaxoSmithKline, Exscientia yields first drug candidate
  • Advaxis and Ayala Pharmaceuticals Complete MergerAdvaxis and Ayala Pharmaceuticals Complete Merger
  • The Future of the ICU? How Clinical Decision Support Is Advancing CareThe Future of the ICU? How Clinical Decision Support Is Advancing Care
  • Lone Star Gold, Inc. announces the acquisition of hemp infused beverage brand “good hemp® “Lone Star Gold, Inc. announces the acquisition of hemp infused beverage brand “good hemp® “
  • How Digital Therapeutics can Go Mainstream in Fragmented U.S. HealthcareHow Digital Therapeutics can Go Mainstream in Fragmented U.S. Healthcare
  • Sanofi completes acquisition of KadmonSanofi completes acquisition of Kadmon
  • Rock Health’s Coo Talks Digital Health Funding, M&as and ’teladongo’Rock Health’s Coo Talks Digital Health Funding, M&as and ’teladongo’

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications